The AACR-MPM Oncology Charitable Foundation Announces First Grants to Support Transformative Cancer Research

PHILADELPHIA, PA and CAMBRIDGE, MA – Two grants for research that could transform cancer therapies have been funded through an innovative partnership between the American Association for Cancer Research (AACR) and MPM Capital through its management of the UBS Oncology Impact Fund (OIF).  This unique grant program allows investigators who can make a significant impact to pursue transformative research.  The AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants program is announcing its first two grants totaling $800,000 in support of research that has the potential to explore new approaches to cancer treatment.  These grants mark only the beginning of a long-term commitment by MPM Capital to finance groundbreaking research, and the program expects to announce another grant opportunity in mid-2020.  “Cancer is the second leading cause of death in the United States, and there is a vital need for high-impact, transformative research that will markedly reduce the incidence, morbidity, and mortality of this devastating disease,” said Margaret Foti, PhD, MD (hc), chief executive officer of the AACR.  “The AACR is delighted to partner with UBS and MPM Capital in support of early-career and mid-career scientists whose exciting research holds promise for catalyzing paradigm-shifting advances in cancer research that will result in breakthroughs in cancer treatment. ”MPM Capital’s investment strategy is focused on developing breakthrough therapies based…

Source: The AACR-MPM Oncology Charitable Foundation Announces First Grants to Support Transformative Cancer Research